Overview

Pediatric Postoperative Analgesia Herniorrhaphy Study

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2, double-blind study in pediatric subjects undergoing inguinal herniorrhaphy.
Phase:
Phase 2
Details
Lead Sponsor:
Heron Therapeutics
Treatments:
Bupivacaine
Epinephrine